HEALTHDAILY MAIL
Millions of breast cancer patients could be spared chemotherapy thanks to groundbreaking gene test
A groundbreaking gene test could spare millions of breast cancer patients from undergoing chemotherapy. The test identifies patients who may not benefit from the treatment, potentially reducing unnecessary side effects.
Related Signal
Adjacent reporting
- Giant cancer study reveals effectiveness of ‘off label’ treatments
- Blood test hints at breast-tumour response to treatment
- How aggressive breast cancer turns off the immune system
- Tumour trap: engineered enhancer sequences enlisted to kill cancer cells
- Scientists discover why some cancers survive chemotherapy
- NHS improves genetic testing for minority ethnic cancer patients